Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elena A. Dobrynina
Assessing the Quality of Life Using the Health Utilities Index Questionnaire in Children With Severe Persistent Asthma During the Treatment With Omalizumab
Pediatric pharmacology
The Long-Term Omalizumab Therapy in Children With Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry
Pediatric pharmacology
Related publications
Prs105 - The Assessment the Health Utilities Index in Children With Severe Persistent Uncontrolled Asthma, Receiving Omalizumab
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prs106 - The Assessment the Quality of Life in Children With Severe Persistent Uncontrolled Asthma, Receiving Omalizumab, by the Health Utilities Index and Standardised Paediatric Asthma Quality of Life Questionnaire(according to the Pediatric Registry)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Lengthening Omalizumab Dosing Interval in Treatment of Moderate to Severe Persistent Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?
European Clinical Respiratory Journal
First Experience With Omalizumab in a Child With Severe Persistent Asthma in Turkey: Case Report
Turkiye Klinikleri Journal of Medical Sciences
Medicine
P170 Long-Term Effectiveness of Omalizumab in Patients With Severe Persistent Allergic (IgE-mediated) Asthma: UK Centre Real-Life Experience
Thorax
Pulmonary
Respiratory Medicine
Assessment of Quality of Life in Asthmatic Children and Their Caregivers After Treatment With Omalizumab
Pediatrics & Therapeutics
